Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity
Saar Ray, M; Moskovich, O; Iosefson, O; Fishelson, Z
HERO ID
2902735
Reference Type
Journal Article
Year
2014
Language
English
PMID
| HERO ID | 2902735 |
|---|---|
| In Press | No |
| Year | 2014 |
| Title | Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity |
| Authors | Saar Ray, M; Moskovich, O; Iosefson, O; Fishelson, Z |
| Journal | Journal of Biological Chemistry |
| Volume | 289 |
| Issue | 21 |
| Page Numbers | 15014-15022 |
| Abstract | Mortalin/GRP75, the mitochondrial heat shock protein 70, plays a role in cell protection from complement-dependent cytotoxicity (CDC). As shown here, interference with mortalin synthesis enhances sensitivity of K562 erythroleukemia cells to CDC, whereas overexpression of mortalin leads to their resistance to CDC. Quantification of the binding of the C5b-9 membrane attack complex to cells during complement activation shows an inverse correlation between C5b-9 deposition and the level of mortalin in the cell. Following transfection, mortalin-enhanced GFP (EGFP) is located primarily in mitochondria, whereas mortalinΔ51-EGFP lacking the mitochondrial targeting sequence is distributed throughout the cytoplasm. Overexpressed cytosolic mortalinΔ51-EGFP has a reduced protective capacity against CDC relative to mitochondrial mortalin-EGFP. Mortalin was previously shown by us to bind to components of the C5b-9 complex. Two functional domains of mortalin, the N-terminal ATPase domain and the C-terminal substrate-binding domain, were purified after expression in bacteria. Similar to intact mortalin, the ATPase domain, but not the substrate-binding domain, was found to bind to complement proteins C8 and C9 and to inhibit zinc-induced polymerization of C9. Binding of mortalin to complement C9 and C8 occurs through an ionic interaction that is nucleotide-sensitive. We suggest that to express its full protective effect from CDC, mortalin must first reach the mitochondria. In addition, mortalin can potentially target the C8 and C9 complement components through its ATPase domain and inhibit C5b-9 assembly and stability. |
| Doi | 10.1074/jbc.M114.552406 |
| Pmid | 24719326 |
| Is Certified Translation | No |
| Dupe Override | No |
| Is Public | Yes |
| Language Text | English |